Syst Rev - Meta An Cubitan 2016
Syst Rev - Meta An Cubitan 2016
Syst Rev - Meta An Cubitan 2016
Abstract: Objectives: The aim of this systematic review was to summarize the evidence on the efficacy of
high-calorie, high-protein nutritional formula enriched with arginine, zinc, and antioxidants (disease-specific
support) in patients with pressure ulcers (PUs). Methods: Randomized controlled trials in English published
from January 1997 until October 2015 were searched for in electronic databases (EMBASE, Medline, PubMed,
and CINAHL). Studies comparing a disease-specific nutritional support (oral supplements or tube feeding)
to a control nutritional intervention enabling the satisfaction of energy requirements regardless of the use of
high-calorie formula or placebo or no support for at least 4 weeks were considered eligible. Study outcomes
were the percentage of change in PU area, complete healing and reduction in the PU area ≥40% at 8 weeks,
and the percentage of change in area at 4 weeks. Results: A total of 3 studies could be included in the meta-
analysis. Compared with control interventions, formulas enriched with arginine, zinc and antioxidants resulted
in significantly higher reduction in ulcer area (-15.7% [95%CI, -29.9, -1.5]; P=0.030; I2=58.6%) and a higher
proportion of participants having a 40% or greater reduction in PU size (OR=1.72 [95%CI, 1.04, 2.84]; P=0.033;
I2=0.0%) at 8 weeks. A nearly significant difference in complete healing at 8 weeks (OR=1.72 [95%CI, 0.86,
3.45]; P=0.127; I2=0.0%) and the percentage of change in the area at 4 weeks (-7.1% [95%CI, -17.4, 3.3];
P=0.180; I2=0.0%) was also observed. Conclusions: This systematic review shows that the use of formulas
enriched with arginine, zinc and antioxidants as oral supplements and tube feeds for at least 8 weeks are
associated with improved PU healing compared with standard formulas.
Table 1
Characteristics of the studies included in quantitative synthesis
Reference Country; setting Study size Malnutrition(%) Study duration Active Control Method used Results *
(active / control) (weeks) intervention intervention in outcome - Mean difference in
[energy ; [energy and assessment reduction in area at 8
proteins] proteins] weeks (%)
- Reduction in area
≥40% at 8 weeks (n)
- Complete healing at
8 weeks (n)
- Mean difference in
reduction in area at 4
weeks (%)
Cereda, 2009 Italy (multi-cen- N=30 (15/15) 90% 12 Oral: standard oral Oral: standard oral Tracing the peri- -24.4% (95%CI, -37.5,
ter); diet + 2 specific diet + 2 standard meter onto sterile, -11.3) ‡
long-term care ONS § per day ONS/day transparent block Active, n=10; Control,
institutions Tube: specific Tube: standard paper and counting n=8
formula # (1000 and high-protein the blocks Active, n=2; Control,
mL/day) + stan- formula as ne- n=0
dard formula as cessary -6.5% (95%CI, -22.8,
necessary [29.5 kcal/kg/day; 9.8) ‡
[30 kcal/kg/day; 1.2 g/kg/day]
1.5 g/kg/day]
Van Anholt, Multi-country; N=43 (22/21) 0% 12 Standard oral diet Standard oral Measuring the 7.3% (95%CI, -18.7,
2010 hospitals + 3 specific ONS diet + 3 bottles maximum length 33.2) †
and § per day [not of non-caloric and width of the Active, n=15; Control,
long-term care reported] placebo/day ulcer with a ruler n=15
institutions [not reported] and assuming the Active, n=6; Control,
surface area of the n=5
ulcer has an ellipse -1.6% (95%CI, -26.7,
form 23.5) †
Cereda, 2015 Italy (multi-cen- N=200 100% 8 Standard oral diet Standard oral diet Tracing the -18.7% (95%CI,
ter); (101/99) + 2 specific ONS + 2 isocaloric, perimeter onto -31.8, -5.7) ‡
long-term care § per day isonitrogenous sterile, transparent Active, n=71; Control,
institutions [27.5 kcal/kg/day; ONS/day paper and using n=54
and 1.5 g/kg/day] [27.0 kcal/kg/day; the VISITRAKTM Active, n=17; Control,
home-care 1.5 g/kg/day] system (resolution n=10
services 0.1 cm2; precision -10.2% (95%CI, -27.0,
of -0.2%–3.3%) 6.5) ‡
Abbreviations: ONS, oral nutritional supplements; 95%CI, 95% confidence interval; * According to multiple imputation of missing outcomes; ‡ Estimates adjusted for pressure ulcer (PU)
area at baseline, PU stage, setting of care, and recruiting center.; † Estimates adjusted for pressure ulcer (PU) area at baseline, PU stage, and recruiting center; § Approximate additional
amount of specific nutrients per each ONS: arginine 3 g; zinc, 4 mcg; copper, 600 mcg; manganese, 1.2 mg; selenium, 40 mcg; vitamin E, 30 mg; vitamin C, 200 mg; # Approximate
additional amount of specific nutrients per 1 litre of formula: arginine 8.5 g; zinc, 8 mcg; copper, 200 mcg; manganese, 0.5 mg; selenium, 40 mcg; vitamin E, 60 mg; vitamin C, 250 mg.
2
J Nutr Health Aging
Statistical Analysis
The meta-analysis was performed using the software
Comprehensive Meta-Analysis, version 2.2.064 (Biostat,
Englewood, NJ - http://www.meta-analysis.com/index.php),
establishing the level of significance at a 2-tailed P<0.05.
For continuous end points (the percentage of reduction
in area at 8 and 4 weeks) we computed the pooled mean
difference between interventions using fully-adjusted estimates.
However, for categorical outcomes (reduction in the area ≥ 40%
and complete healing at 8 weeks) risk ratios were calculated
using the number of events. For all the outcomes we pooled
estimates calculated using according to the multiple imputation
of missing outcomes. All estimates were provided along with
95% confidence interval (95%CI).
The search identified 1249 non duplicate potentially eligible Study outcomes
studies. After excluding 1225 papers through title and abstract For all the trials fulfilling inclusion criteria for quantitative
review, 24 full text articles were examined. Altogether, 9 synthesis it was possible to collect data on the outcomes
studies were included in the qualitative synthesis and 3 in considered. In primary analysis, based on all trials, the use
meta-analysis (Figure 1) (15-17). A description of the articles of a disease specific nutritional support was associated with
excluded (13,14,24-27) is provided in the Supplementary a significantly higher reduction in ulcer area (Figure 1) and
Table 1. Particularly, study were excluded due to the following a higher proportion of participants having a 40% or greater
reasons: short duration (n=2) (14, 29); outcome data not reduction in PU size at 8 weeks (Table 3). Besides, we observed
available (n=2) (13, 24); inclusion of patients with different a nearly significant difference in complete healing at 8 weeks
types of chronic wounds (n=1) (26); lack of a control group and the percentage of change in the area at 4 weeks with
3
J Nutr Health Aging
Table 2
Risk of bias of RCTs included in quantitative synthesis
Reference Evaluation of the Random sequence Allocation conceal- Blinding of Incomplete Selective outcome Differences
study based on generation ment (selection patients and outcome data reporting in baseline
(selection bias) bias) outcome assessors (attrition bias) (reporting bias) characteristics
(performance and between arms
detection bias)
Cereda, 2009 Manuscript review ↑ ? ↑ ↑ ↑ More patients with
multiple PUs in
the disease-specific
group
Request to the ↑ ↑ ↑ ↑ ↑
authors
Van Anholt, 2010 Manuscript review ? ? ↑ ↑ ↑ None
Request to the ↑ ↑ ↑ ↑ ↑
authors
Cereda, 2015 Manuscript review ↑ ↑ ↑ ↑ ↑ None
Request to the ↑ ↑ ↑ ↑ ↑
authors
Risk of bias - rating: ↑ low; ↓ high; ?, unclear.
Table 3
Secondary efficacy end points
no heterogeneity (I2=0.0% for all). These findings were of a disease-specific formula enriched with arginine, zinc
substantially confirmed by sensitivity analysis (Table 3) and antioxidants in the nutritional support of PU patients.
refitted on studies including malnourished patients (15, 17). Accordingly, it strengthens the recent recommendations
Particularly, in respect to the primary outcome we observed an included in the NPUAP-EPUAP-PPPIA international guidelines
increase in the pooled effect size with no heterogeneity (Figure released in 2014 (11). Interestingly, the use of this formula has
1). been found to be also cost-effective, as it enables reducing the
intensity of local care (18).
Publication Bias Results on efficacy are consistent with and expand
Visual inspection of funnel plots showed that publication those of a previous meta-analysis (31) reporting a trend to
bias was unlikely. improved healing from the use of a disease-specific formula.
Unfortunately, the analysis was based on the findings
Discussion of small trials (13-16, 26) and did not consider those of the
OligoElement Sore Trial (OEST), a large trial with a low risk
Despite the wide availability of nutritional formulae, many of bias specifically addressing the independent role of specific
of which are marketed for specific disease conditions, there is nutrients in wound healing (18). Arginine is a semiessential
limited evidence supporting their efficacy and use in clinical amino acid contributing to protein anabolism (e.g collagen
practice (28-30). This is an important issue as these formula synthesis), cellular growth. As a donor of nitric oxide, it can
are usually more expensive than standard ones. Our meta- also increase tissue blood flow, improve immune response and
analysis reasonably supports as Grade A evidence for the use induce the mobilization of endothelial progenitor cells from
4
J Nutr Health Aging
Figure 2
Forest plot of the percentage of change in ulcer area at 8 weeks in participants receiving disease-specific vs control nutritional
support. In the plots, the squares indicate point estimates of effect (mean difference), with the size of the square representing
the weight attributed to each study and the horizontal bars indicating 95%CI. Sensitivity analysis is based on studies including
malnourished participants
the bone marrow. Zinc is an important co-enzyme of enzymes size due to unavailability of non-malnourished patients. In
involved in protein and DNA synthesis, immune function, agreement with this, the OEST study has found that about 90%
and cellular proliferation. Antioxidants are also relevant in of PU patients are malnourished (17). Therefore, PU patients
any chronic inflammatory condition. Particulalry, vitamin are likely malnourished and nutritional support should be
C plays an important role in cellular immunity, fibroblast systematically considered.
proliferation and the synthesis of collagen (32, 33). Previous The following limitations are acknowledged. First, despite
trials were not able to demonstrate a positive effect for these using multiple database we searched only for English-language
single micronutrients and the failure was likely due to the lack full-text articles. Second, only 3 high-quality trials have been
of concomitant energy supply (17, 31). included in the present meta-analysis. Other studies have
The present meta-analysis has shown that nutritional considered the use of a disease-specific nutritional support
support should be at least 8-week long and primarily directed in PU patients (13, 14, 24-27). Although they did not fulfill
to malnourished patients as these reasonably more likely to criteria for inclusion in quantitative synthesis they have all
be characterized by low values of several nutrients. Although shown a positive effect of supplementation with nutrients
van Anholt et al. have reported a significant difference in PU playing a role in wound healing (arginine + different
healing over time (faster improvement in the initial phases combination of other nutrients) on mixed healing outcomes
of the study with a reduction in the intensity of care) in non- (Pressure Ulcer Scale for Healing [PUSH]; complete healing;
malnourished patients, at 8 weeks the reduction in PU area time to complete healing; improved tissue viability). On
appeared to be comparable to that obtained in the placebo the other hand, the limited number of studies included in
group (16). Interestingly, this was the only trial – among those quantitative synthesis highlights the important methodological
included in quantitative synthesis – in which a significant limitations in this research area. Besides, we cannot exclude
difference in protein-calorie support between treatment arms that multiple separate micronutrient supplements provided in
was present. Besides, a less accurate method of assessment of combination with a high-calorie, high-protein formula have the
ulcer area was used and not description of how pressure (a key same effectiveness of a all-in-one oral nutritional supplement.
estrinsic factor for PU) was managed (e.g. mattresses/overlays, Third, complete healing is an important outcome in wound care.
repositioning protocol, etc...). It is also worth mentioning that However, most available studies did not consider a support
the study was stopped before reaching the estimated sample until complete healing and have included it as a secondary
5
J Nutr Health Aging
Ethical standard: The study did not required the approval of the Ethics Committee.
Supplementary Table 1
Characteristics of the randomized trials undergoing qualitative review and excluded from quantitative synthesis
6
J Nutr Health Aging
References 18. Cereda E, Klersy C, Andreola M, Pisati R, Schols JM, Caccialanza R, D’Andrea
F; OligoElement Sore Trial (OEST) Study Group. Cost-effectiveness of a disease-
specific oral nutritional support for pressure ulcer healing. Clin Nutr. 2015;
1. Bernabei R, Manes-Gravina E, Mammarella F. Epidemiology of pressure ulcers doi:10.1016/j.clnu.2015.11.012. [Epub ahead of print]
[Epidemiologia delle piaghe da decubito]. G Gerontol 2011;59:237-243 19. Schünemann H, Brözek J, Guyatt G, Oxman A, editors. GRADE handbook for
2. Smith DM. Pressure ulcers in the nursing home. Ann Intern Med 1995;123:433-442. grading quality of evidence and strength of recommendations. The GRADE Working
3. Dealey C, Posnett J, Walker A. The cost of pressure ulcers in the United Kingdom. J Group. Updated October 2013. Available at: www.guideline development.org/
Wound Care 2012;21:261-2, 264, 266. handbook; 2013.
4. Smith ME, Totten A, Hickam DH, Fu R, Wasson N, Rahman B, Motu’apuaka M, 20. Scottish Intercollegiate Guidelines Network. Sign 50: A guideline developers´
Saha S. Pressure ulcer treatment strategies: a systematic comparative effectiveness handbook. Edinburgh: Scottish Intercollegiate Guidelines Network. Available at:
review. Ann Intern Med 2013;159:39-50. http://www.sign.ac.uk/
5. Posthauer ME, Banks M, Dorner B, Schols JM. The role of nutrition for pressure 21. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting
ulcer management: national pressure ulcer advisory panel, European pressure ulcer items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern
advisory panel, and pan pacific pressure injury alliance white paper. Adv Skin Wound Med 2009;151:W65–W94.
Care. 2015 Apr;28(4):175-88 22. Benati G, Bertone MS, Cereda E, Ciprandi G, Masina M, Pedrolli C, Sidoli O,
6. Shahin ES, Meijers JM, Schols JM, Tannen A, Halfens RJ, Dassen T. The Vertsonis G. Nutritional Treatment in Patients with Pressure Ulcers. Acta Vulnol
relationship between malnutrition parameters and pressure ulcers in hospitals and 2011;9(3):27-127
nursing homes. Nutrition 2010;26:886-889. 23. Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group and
7. Litchford MD, Dorner B, Posthauer ME. Malnutrition as a Precursor of Pressure the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included
Ulcers. Adv Wound Care (New Rochelle). 2014 Jan 1;3(1):54-63. studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic
8. Cereda E, Klersy C, Rondanelli M, Caccialanza R. Energy balance in patients with Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011 [updated
pressure ulcers: a systematic review and meta-analysis of observational studies. J Am March 2011].
Diet Assoc 2011;111:1868-1876. 25. Benati G, Gasparoni R, Coppola D. Supplementation with arginine, glutamine and
9. Qaseem A, Humphrey LL, Forciea MA, Starkey M, Denberg TD; Clinical Guidelines β-hydroxy β-methylbutyrate (βHMB) can improve pressure ulcer healing, reduce
Committee of the American College of Physicians. Treatment of pressure ulcers: a pain and frequency of dressing changes, improving costs. Clin Nutr Suppl. 2012;
clinical practice guideline from the American College of Physicians. Ann Intern Med. 7(1):269
2015 Mar 3;162(5):370-9. 26. Leigh B, Desneves K, Rafferty J, Pearce L, King S, Woodward MC, Brown D,
10. Cereda E. Treatment of Pressure Ulcers. Ann Intern Med. 2015 Oct 20;163(8):646-7. Martin R, Crowe TC. The effect of different doses of an arginine-containing
11. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel supplement on the healing of pressure ulcers. J Wound Care. 2012 Mar;21(3):150-6.
and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure 27. Bauer JD, Isenring E, Waterhouse M. The effectiveness of a specialised oral nutrition
Ulcers: Clinical Practice Guideline. Emily Haesler (Ed.). Cambridge Media: Perth, supplement on outcomes in patients with chronic wounds: a pragmatic randomised
Australia; 2014. study. J Hum Nutr Diet. 2013 Oct;26(5):452-8.
12. National Pressure Ulcer Advisory Panel (NPUAP), European Pressure Ulcer 28. Wong A, Chew A, Wang CM, Ong L, Zhang SH, Young S. The use of a specialised
Advisory Panel (EPUAP). Prevention and Treatment of Pressure Ulcers: Clinical amino acid mixture for pressure ulcers: a placebo-controlled trial. J Wound Care.
Practice Guideline. Washington, DC: National Pressure Ulcer Advisory Panel; 2009. 2014 May;23(5):259-60, 262-4, 266-9.
13. Benati G, Delvecchio S, Cilla D, Pedone V. Impact on pressure ulcer healing of an 29. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional
arginine-enriched nutritional solution in patients with severe cognitive impairment. support and use of diabetes-specific formulas for patients with diabetes: a systematic
Arch Gerontol Geriatr Suppl 2001;7:43–47. review and meta-analysis. Diabetes Care. 2005 Sep;28(9):2267-79.
14. Desneves KJ, Todorovic BE, Cassar A, Crowe TC. Treatment with supplementary 30. ESPEN Guidelines on Enteral Nutrition. Clin Nutr 2006;25:175-360.
arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled 31. McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig
trial. Clin Nutr 2005;24:979-987. C, McCarthy MS, Davanos E, Rice TW, Cresci GA, Gervasio JM, Sacks GS, Roberts
15. Cereda E, Gini A, Pedrolli C, Vanotti A. Disease-specific, versus standard, nutritional PR, Compher C; Society of Critical Care Medicine; American Society for Parenteral
support for the treatment of pressure ulcers in institutionalized older adults: A and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition
randomized controlled trial. J Am Geriatr Soc 2009;57:1395-1402. Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine
16. van Anholt RD, Sobotka L, Meijer EP, Heyman H, Groen HW, Topinková E, (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).
van Leen M, Schols JM. Specific nutritional support accelerates pressure ulcer JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211.
healing and reduces wound care intensity in nonmalnourished patients. Nutrition 32. Langer G, Fink A. Nutritional interventions for preventing and treating pressure
2010;26:867-872. ulcers. Cochrane Database Syst Rev. 2014 Jun 12;6:CD003216.
17. Cereda E, Klersy C, Serioli M, Crespi A, D’Andrea F; OligoElement Sore Trial 33. Stechmiller JK. Understanding the role of nutrition and wound healing. Nutr Clin
Study Group. A nutritional formula enriched with arginine, zinc, and antioxidantsnfor Pract 2010;25:61-68.
the healing of pressure ulcers: a randomized trial. Ann Intern Med. 2015 Feb 34. Doley J. Nutrition management of pressure ulcers. Nutr Clin Pract 2010;25:50-60.
3;162(3):167-74.
7
J Nutr Health Aging
8
Copyrights and Use Restrictions.